We are live on ! Find out more
SYRA

Syra Health Corp. Class A Common Stock
SYRA

Delisted

SYRA was delisted on the 17th of April, 2025.

Back to rankings

13 hedge funds and large institutions have $299K invested in Syra Health Corp. Class A Common Stock in 2024 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 5 increasing their positions, 0 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

215% more capital invested

Capital invested by funds: $94.8K → $299K (+$204K)

133% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 3

44% more funds holding

Funds holding: 9 → 13 (+4)

Holders
13
Holders Change
+4
Holders Change %
+44.44%
% of All Funds
0.19%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
5
Reduced
–
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
CCC
Cable Car Capital
California
+$274K
2
WAM
Warberg Asset Management
Illinois
+$221K
3
Citadel Advisors
Citadel Advisors
Florida
+$63.9K
4
VF
Virtu Financial
New York
+$31.4K
5
TSS
Two Sigma Securities
New York
+$27.5K

Top Sellers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
-$2.28K
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$166
3
JP Morgan Chase
JP Morgan Chase
New York
-$14

SYRA Hedge Fund Activity: Q3 2024 in Review

13 of the 6,978 institutional investors tracked by Wall St. Rank reported a position in Syra Health Corp. Class A Common Stock (SYRA) for Q3 2024, worth a combined $299K — up 215% from $94.8K a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new SYRA positions and 3 closed out — a net gain of 4 holders — while 5 added to existing stakes and 0 trimmed.

The largest buyer was Cable Car Capital, opening a new position worth an estimated $274K. The largest seller was UBS Group, exiting entirely with an estimated $2.28K sold.

  • 13 institutional investors held Syra Health Corp. Class A Common Stock (SYRA) as of Q3 2024, up from 9 in Q2 2024.
  • Funds reported $299K of Syra Health Corp. Class A Common Stock stock for Q3 2024, up 215% quarter-over-quarter.
  • 7 funds opened new Syra Health Corp. Class A Common Stock positions in Q3 2024 and 3 closed out, a net change of +4 holders.
  • The largest Syra Health Corp. Class A Common Stock buyer in Q3 2024 was Cable Car Capital, an estimated $274K added.
  • The largest Syra Health Corp. Class A Common Stock seller in Q3 2024 was UBS Group, an estimated $2.28K sold.

Based on aggregated 13F filings for Q3 2024.